Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-10-01 BENZENO SHARON Chief Business Development Off Option exercise +2,605 $6.55 $17K 5,209
2020-10-01 BENZENO SHARON Chief Business Development Off Option exercise +1,562 $7.27 $11K 6,771
2020-10-01 BENZENO SHARON Chief Business Development Off Sale −5,878 $48.46 $285K 893
2020-10-01 BENZENO SHARON Chief Business Development Off Sale −893 $49.26 $44K 0
2020-10-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 33,855
2020-10-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,605 62,500
2020-10-01 BENZENO SHARON Chief Business Development Off Option exercise · Common Stock (Right to Buy) −1,562 42,188
2020-10-01 DOBMEIER ERIC Director Option exercise +10,000 $6.32 $63K 10,000
2020-10-01 DOBMEIER ERIC Director Sale −9,224 $48.47 $447K 776
2020-10-01 DOBMEIER ERIC Director Sale −776 $49.21 $38K 0
2020-10-01 DOBMEIER ERIC Director Option exercise · Stock Option (Right to Buy) −10,000 45,000
2020-10-01 RUBINSTEIN JULIE President Option exercise +14,725 $0.84 $12K 14,725
2020-10-01 RUBINSTEIN JULIE President Sale −14,725 $49.00 $722K 0
2020-10-01 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −14,725 0
2020-10-01 ROBINS CHAD M CEO and Chairman Option exercise +600 $0.33 $198 1,778,780
2020-10-01 ROBINS CHAD M CEO and Chairman Sale −600 $50.05 $30K 1,778,180
2020-10-01 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −600 192,140
2020-09-29 RUBINSTEIN JULIE President Option exercise +80,000 $0.84 $67K 80,000
2020-09-29 RUBINSTEIN JULIE President Sale −80,000 $49.00 $3.9M 0
2020-09-29 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −80,000 14,725

Page 88 of 120 · 2,386 trades